India’s top drug regulator has acknowledged serious lapses in pharmaceutical manufacturing practices, amid growing outrage over child deaths allegedly linked to contaminated cough syrups.
India’s top drug regulator has acknowledged serious lapses in pharmaceutical manufacturing practices, amid growing outrage over child deaths allegedly linked to contaminated cough syrups.